Abstract
Bacterial and viral pathogens are devastating to human health and well-being. In many regions, dozens of pathogen species and variants co-circulate. Thus, it is important to detect many different species and variants of pathogens in a given sample through multiplexed detection methods. CRISPR-based nucleic acid detection has shown to be a promising step towards an easy-to-use, sensitive, specific, and high-throughput method to detect nucleic acids from DNA and RNA viruses and bacteria. Here, we review the current state of multiplexed nucleic acid detection methods with a focus on CRISPR-based methods. We also look toward the future of multiplexed point-of-care diagnostics.
Original language | English (US) |
---|---|
Article number | 100471 |
Journal | Current Opinion in Biomedical Engineering |
Volume | 27 |
DOIs | |
State | Published - Sep 2023 |
All Science Journal Classification (ASJC) codes
- Bioengineering
- Medicine (miscellaneous)
- Biomaterials
- Biomedical Engineering
Keywords
- CRISPR
- Multiplexing
- Nucleic acid amplification
- Pathogen detection
- Point-of-care